Cites del registre
Cita APA (7th ed.)
Hirayama, Y., Tam, T., Jian, K., Andersen, R. J., & Sadar, M. D. (2020). Combination therapy with androgen receptor N‐terminal domain antagonist EPI‐7170 and enzalutamide yields synergistic activity in AR‐V7‐positive prostate cancer. Wiley.
Copiat
No s'ha pogut copiar
Cita Chicago (17th ed.)
Hirayama, Yukiyoshi, Teresa Tam, Kunzhong Jian, Raymond J. Andersen, i Marianne D. Sadar. Combination Therapy with Androgen Receptor N‐terminal Domain Antagonist EPI‐7170 and Enzalutamide Yields Synergistic Activity in AR‐V7‐positive Prostate Cancer. Wiley, 2020.
Copiat
No s'ha pogut copiar
Cita MLA (9th ed.)
Hirayama, Yukiyoshi, et al. Combination Therapy with Androgen Receptor N‐terminal Domain Antagonist EPI‐7170 and Enzalutamide Yields Synergistic Activity in AR‐V7‐positive Prostate Cancer. Wiley, 2020.
Copiat
No s'ha pogut copiar
Atenció: Aquestes cites poden no estar 100% correctes.